Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2003

A trial of objective comparison of quality of life between chronic renal failure patients treated with hemodialysis and renal transplantation.

Tomasz Wesołowski, Piotr Szyber

Ann Transplant 2003; 8(2): 48-54 :: ID: 142803

Abstract

An interesting issue is a hemodialysis patients' and renal transplant recipients'subjective assessment of their QOL as a basic sociological criterion of treatment efficacy. The aim ofthe study is an estimation and comparison of QOL between these patients with a questionnaire the WHOQOL-100as a trial of objective comparison of quality of life between these two groups of patients. A methodof diagnostic probing with use of the questionnaire in its Polish language version was employed. A numberof 400 (in total) questionnaires (200 in each group) were given to randomly chosen CRF patients. Fulfilledquestionnaires were obtained from 144 (36%) patients who underwent the study: 61 from HD group (30.5%)and 83 from TX group (41.5%). RESULTS: Regarding sex and education, differences between groups were notsignificant statistically. As for the age and marital status, differences between groups were significant(p = 2.5 E-13 and p = 0.0045 respectively). In the both groups, (living from the health pension fromthe Government Health Insurance--ZUS) was overwhelming (HD--96.12% and TX--77.11%). A difference in amountof 'having a job' patients between groups was not significant (p = 0.153). In QOL estimation, significantdifferences between group HD and TX were assessed in overall QOL (p = 1.04 E-07), in physical domain(p = 0.00053) and social relationships domain (p = 0.0004). In the rest of domains, scores were approximatein both groups and did not differ significantly. Comparing facets scores, some significant differencesbetween HD and TX groups were observed: pain and discomfort (p = 0.032), energy and fatigue (p = 2.2E-05), positive feelings (p = 0.002), body image and appearance (p = 0.010), mobility (p = 0.031), activitiesof daily living (p = 0.036), working capacity (p = 0.008), personal relationships (p = 0.004), sexualactivity (p = 7.3 E-06) and transport (p = 0.036). Higher scores were stated in TX group in all of thosefacets excluding body image and appearance and pain and discomfort. CONCLUSIONS: 1) TX patients QOL isbetter than HD patients' in domains: overall, physical, social relationships and environment and alsoin facets: pain and discomfort, energy and fatigue, positive feelings, mobility, activities of dailyliving, working capacity, personal relationships, sexual activity and transport. 2) In the facet bodyimage and appearance, TX patients' QOL is worse than HD patients'. 3) The results point out the WHOQOL-100to be a useful and reliable instrument for measuring quality of life in different populations makingpossible to compare it objectively.

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358